Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016

Background It was recently shown that new-onset diabetes patients without previous cardiovascular disease have experienced a markedly reduced risk of adverse cardiovascular events from 1996 to 2011. However, it remains unknown if similar improvements are present following the diagnosis of chronic co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cardiovascular Disorders 2021, Vol.21 (1)
Hauptverfasser: Jensen, Esben Skov, Olesen, Kevin Kris Warnakula, Gyldenkerne, Christine, Thrane, Pernille Gro, Jensen, Lisette Okkels, Raungaard, Bent, Poulsen, Per Lagstrup, Thomsen, Reimar Wernich, Maeng, Michael
Format: Report
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page
container_title BMC Cardiovascular Disorders
container_volume 21
creator Jensen, Esben Skov
Olesen, Kevin Kris Warnakula
Gyldenkerne, Christine
Thrane, Pernille Gro
Jensen, Lisette Okkels
Raungaard, Bent
Poulsen, Per Lagstrup
Thomsen, Reimar Wernich
Maeng, Michael
description Background It was recently shown that new-onset diabetes patients without previous cardiovascular disease have experienced a markedly reduced risk of adverse cardiovascular events from 1996 to 2011. However, it remains unknown if similar improvements are present following the diagnosis of chronic coronary syndrome. The purpose of this study was to examine the change in cardiovascular risk among diabetes patients with chronic coronary syndrome from 2004 to 2016. Methods We included patients with documentation of coronary artery disease by coronary angiography between 2004 and 2016 in Western Denmark. Patients were stratified by year of index coronary angiography (2004-2006, 2007-2009, 2010-2012, and 2013-2016) and followed for two years. The main outcome was major adverse cardiovascular events (MACE) defined as myocardial infarction, ischemic stroke, or death. Analyses were performed separately in patients with and without diabetes. We estimated two-year risk of each outcome and adjusted incidence rate ratios (aIRR) using patients examined in 2004-2006 as reference. Results Among 5931 patients with diabetes, two-year MACE risks were 8.4% in 2004-2006, 8.5% in 2007-2009, and then decreased to 6.2% in 2010-2012 and 6.7% in 2013-2016 (2013-2016 vs 2004-2006: aIRR 0.70, 95% CI 0.53-0.93). In comparison, 23,540 patients without diabetes had event rates of 6.3%, 5.2%, 4.2%, and 3.9% for the study intervals (2013-2016 vs 2004-2006: aIRR 0.57, 95% CI 0.48-0.68). Conclusions Between 2004 and 2016, the two-year relative risk of MACE decreased by 30% in patients with diabetes and chronic coronary syndrome, but slightly larger absolute and relative reductions were observed in patients without diabetes. Keywords: Diabetes, Coronary artery disease, Major adverse cardiovascular event, Trend
doi_str_mv 10.1186/s12872-021-02312-y
format Report
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracacademiconefile_A686398222</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A686398222</galeid><sourcerecordid>A686398222</sourcerecordid><originalsourceid>FETCH-gale_infotracacademiconefile_A6863982223</originalsourceid><addsrcrecordid>eNqVTEtOAzEUixBIlM8FWOUCKXlvqky6RBWIA7BHjyTTvnaajJIUNLcnfBZskWXZsmwLcQd6CWDNfQG0PSqN0NgBqvlMLGDVg0I0cP7HX4qrUvZaQ2_1eiGmDWXP6Z2KO42UZeZykBzlRJVDrEV-cN1Jiv7bpFOVnukt1FDklENpFY7bn5Lb5RTZSZeaUp5lmaPP6Ri-_lDrlUIN5kZcDDSWcPur12L59PiyeVZbGsMrxyHVTK7BhyO7FMPALX8w1nRri4jdvwefV25Zew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016</title><source>Springer Nature - Complete Springer Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Jensen, Esben Skov ; Olesen, Kevin Kris Warnakula ; Gyldenkerne, Christine ; Thrane, Pernille Gro ; Jensen, Lisette Okkels ; Raungaard, Bent ; Poulsen, Per Lagstrup ; Thomsen, Reimar Wernich ; Maeng, Michael</creator><creatorcontrib>Jensen, Esben Skov ; Olesen, Kevin Kris Warnakula ; Gyldenkerne, Christine ; Thrane, Pernille Gro ; Jensen, Lisette Okkels ; Raungaard, Bent ; Poulsen, Per Lagstrup ; Thomsen, Reimar Wernich ; Maeng, Michael</creatorcontrib><description>Background It was recently shown that new-onset diabetes patients without previous cardiovascular disease have experienced a markedly reduced risk of adverse cardiovascular events from 1996 to 2011. However, it remains unknown if similar improvements are present following the diagnosis of chronic coronary syndrome. The purpose of this study was to examine the change in cardiovascular risk among diabetes patients with chronic coronary syndrome from 2004 to 2016. Methods We included patients with documentation of coronary artery disease by coronary angiography between 2004 and 2016 in Western Denmark. Patients were stratified by year of index coronary angiography (2004-2006, 2007-2009, 2010-2012, and 2013-2016) and followed for two years. The main outcome was major adverse cardiovascular events (MACE) defined as myocardial infarction, ischemic stroke, or death. Analyses were performed separately in patients with and without diabetes. We estimated two-year risk of each outcome and adjusted incidence rate ratios (aIRR) using patients examined in 2004-2006 as reference. Results Among 5931 patients with diabetes, two-year MACE risks were 8.4% in 2004-2006, 8.5% in 2007-2009, and then decreased to 6.2% in 2010-2012 and 6.7% in 2013-2016 (2013-2016 vs 2004-2006: aIRR 0.70, 95% CI 0.53-0.93). In comparison, 23,540 patients without diabetes had event rates of 6.3%, 5.2%, 4.2%, and 3.9% for the study intervals (2013-2016 vs 2004-2006: aIRR 0.57, 95% CI 0.48-0.68). Conclusions Between 2004 and 2016, the two-year relative risk of MACE decreased by 30% in patients with diabetes and chronic coronary syndrome, but slightly larger absolute and relative reductions were observed in patients without diabetes. Keywords: Diabetes, Coronary artery disease, Major adverse cardiovascular event, Trend</description><identifier>ISSN: 1471-2261</identifier><identifier>EISSN: 1471-2261</identifier><identifier>DOI: 10.1186/s12872-021-02312-y</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Cardiovascular diseases ; Complications and side effects ; Diabetes ; Risk factors ; Statistics</subject><ispartof>BMC Cardiovascular Disorders, 2021, Vol.21 (1)</ispartof><rights>COPYRIGHT 2021 BioMed Central Ltd.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,860,4476,27902</link.rule.ids></links><search><creatorcontrib>Jensen, Esben Skov</creatorcontrib><creatorcontrib>Olesen, Kevin Kris Warnakula</creatorcontrib><creatorcontrib>Gyldenkerne, Christine</creatorcontrib><creatorcontrib>Thrane, Pernille Gro</creatorcontrib><creatorcontrib>Jensen, Lisette Okkels</creatorcontrib><creatorcontrib>Raungaard, Bent</creatorcontrib><creatorcontrib>Poulsen, Per Lagstrup</creatorcontrib><creatorcontrib>Thomsen, Reimar Wernich</creatorcontrib><creatorcontrib>Maeng, Michael</creatorcontrib><title>Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016</title><title>BMC Cardiovascular Disorders</title><description>Background It was recently shown that new-onset diabetes patients without previous cardiovascular disease have experienced a markedly reduced risk of adverse cardiovascular events from 1996 to 2011. However, it remains unknown if similar improvements are present following the diagnosis of chronic coronary syndrome. The purpose of this study was to examine the change in cardiovascular risk among diabetes patients with chronic coronary syndrome from 2004 to 2016. Methods We included patients with documentation of coronary artery disease by coronary angiography between 2004 and 2016 in Western Denmark. Patients were stratified by year of index coronary angiography (2004-2006, 2007-2009, 2010-2012, and 2013-2016) and followed for two years. The main outcome was major adverse cardiovascular events (MACE) defined as myocardial infarction, ischemic stroke, or death. Analyses were performed separately in patients with and without diabetes. We estimated two-year risk of each outcome and adjusted incidence rate ratios (aIRR) using patients examined in 2004-2006 as reference. Results Among 5931 patients with diabetes, two-year MACE risks were 8.4% in 2004-2006, 8.5% in 2007-2009, and then decreased to 6.2% in 2010-2012 and 6.7% in 2013-2016 (2013-2016 vs 2004-2006: aIRR 0.70, 95% CI 0.53-0.93). In comparison, 23,540 patients without diabetes had event rates of 6.3%, 5.2%, 4.2%, and 3.9% for the study intervals (2013-2016 vs 2004-2006: aIRR 0.57, 95% CI 0.48-0.68). Conclusions Between 2004 and 2016, the two-year relative risk of MACE decreased by 30% in patients with diabetes and chronic coronary syndrome, but slightly larger absolute and relative reductions were observed in patients without diabetes. Keywords: Diabetes, Coronary artery disease, Major adverse cardiovascular event, Trend</description><subject>Cardiovascular diseases</subject><subject>Complications and side effects</subject><subject>Diabetes</subject><subject>Risk factors</subject><subject>Statistics</subject><issn>1471-2261</issn><issn>1471-2261</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2021</creationdate><recordtype>report</recordtype><sourceid/><recordid>eNqVTEtOAzEUixBIlM8FWOUCKXlvqky6RBWIA7BHjyTTvnaajJIUNLcnfBZskWXZsmwLcQd6CWDNfQG0PSqN0NgBqvlMLGDVg0I0cP7HX4qrUvZaQ2_1eiGmDWXP6Z2KO42UZeZykBzlRJVDrEV-cN1Jiv7bpFOVnukt1FDklENpFY7bn5Lb5RTZSZeaUp5lmaPP6Ri-_lDrlUIN5kZcDDSWcPur12L59PiyeVZbGsMrxyHVTK7BhyO7FMPALX8w1nRri4jdvwefV25Zew</recordid><startdate>20211204</startdate><enddate>20211204</enddate><creator>Jensen, Esben Skov</creator><creator>Olesen, Kevin Kris Warnakula</creator><creator>Gyldenkerne, Christine</creator><creator>Thrane, Pernille Gro</creator><creator>Jensen, Lisette Okkels</creator><creator>Raungaard, Bent</creator><creator>Poulsen, Per Lagstrup</creator><creator>Thomsen, Reimar Wernich</creator><creator>Maeng, Michael</creator><general>BioMed Central Ltd</general><scope/></search><sort><creationdate>20211204</creationdate><title>Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016</title><author>Jensen, Esben Skov ; Olesen, Kevin Kris Warnakula ; Gyldenkerne, Christine ; Thrane, Pernille Gro ; Jensen, Lisette Okkels ; Raungaard, Bent ; Poulsen, Per Lagstrup ; Thomsen, Reimar Wernich ; Maeng, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_infotracacademiconefile_A6863982223</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cardiovascular diseases</topic><topic>Complications and side effects</topic><topic>Diabetes</topic><topic>Risk factors</topic><topic>Statistics</topic><toplevel>online_resources</toplevel><creatorcontrib>Jensen, Esben Skov</creatorcontrib><creatorcontrib>Olesen, Kevin Kris Warnakula</creatorcontrib><creatorcontrib>Gyldenkerne, Christine</creatorcontrib><creatorcontrib>Thrane, Pernille Gro</creatorcontrib><creatorcontrib>Jensen, Lisette Okkels</creatorcontrib><creatorcontrib>Raungaard, Bent</creatorcontrib><creatorcontrib>Poulsen, Per Lagstrup</creatorcontrib><creatorcontrib>Thomsen, Reimar Wernich</creatorcontrib><creatorcontrib>Maeng, Michael</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jensen, Esben Skov</au><au>Olesen, Kevin Kris Warnakula</au><au>Gyldenkerne, Christine</au><au>Thrane, Pernille Gro</au><au>Jensen, Lisette Okkels</au><au>Raungaard, Bent</au><au>Poulsen, Per Lagstrup</au><au>Thomsen, Reimar Wernich</au><au>Maeng, Michael</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016</atitle><jtitle>BMC Cardiovascular Disorders</jtitle><date>2021-12-04</date><risdate>2021</risdate><volume>21</volume><issue>1</issue><issn>1471-2261</issn><eissn>1471-2261</eissn><abstract>Background It was recently shown that new-onset diabetes patients without previous cardiovascular disease have experienced a markedly reduced risk of adverse cardiovascular events from 1996 to 2011. However, it remains unknown if similar improvements are present following the diagnosis of chronic coronary syndrome. The purpose of this study was to examine the change in cardiovascular risk among diabetes patients with chronic coronary syndrome from 2004 to 2016. Methods We included patients with documentation of coronary artery disease by coronary angiography between 2004 and 2016 in Western Denmark. Patients were stratified by year of index coronary angiography (2004-2006, 2007-2009, 2010-2012, and 2013-2016) and followed for two years. The main outcome was major adverse cardiovascular events (MACE) defined as myocardial infarction, ischemic stroke, or death. Analyses were performed separately in patients with and without diabetes. We estimated two-year risk of each outcome and adjusted incidence rate ratios (aIRR) using patients examined in 2004-2006 as reference. Results Among 5931 patients with diabetes, two-year MACE risks were 8.4% in 2004-2006, 8.5% in 2007-2009, and then decreased to 6.2% in 2010-2012 and 6.7% in 2013-2016 (2013-2016 vs 2004-2006: aIRR 0.70, 95% CI 0.53-0.93). In comparison, 23,540 patients without diabetes had event rates of 6.3%, 5.2%, 4.2%, and 3.9% for the study intervals (2013-2016 vs 2004-2006: aIRR 0.57, 95% CI 0.48-0.68). Conclusions Between 2004 and 2016, the two-year relative risk of MACE decreased by 30% in patients with diabetes and chronic coronary syndrome, but slightly larger absolute and relative reductions were observed in patients without diabetes. Keywords: Diabetes, Coronary artery disease, Major adverse cardiovascular event, Trend</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s12872-021-02312-y</doi></addata></record>
fulltext fulltext
identifier ISSN: 1471-2261
ispartof BMC Cardiovascular Disorders, 2021, Vol.21 (1)
issn 1471-2261
1471-2261
language eng
recordid cdi_gale_infotracacademiconefile_A686398222
source Springer Nature - Complete Springer Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Cardiovascular diseases
Complications and side effects
Diabetes
Risk factors
Statistics
title Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004-2016
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A27%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Cardiovascular%20risk%20in%20patients%20with%20and%20without%20diabetes%20presenting%20with%20chronic%20coronary%20syndrome%20in%202004-2016&rft.jtitle=BMC%20Cardiovascular%20Disorders&rft.au=Jensen,%20Esben%20Skov&rft.date=2021-12-04&rft.volume=21&rft.issue=1&rft.issn=1471-2261&rft.eissn=1471-2261&rft_id=info:doi/10.1186/s12872-021-02312-y&rft_dat=%3Cgale%3EA686398222%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A686398222&rfr_iscdi=true